SciELO - Scientific Electronic Library Online

 
vol.53 issue2Sexuality on breast or cervical cancer patients with surgical treatment at Hospital General, Hospital San Vicente de Paúl and Instituto de Cancerología de la Clínica de las Américas, Medellín, 1999 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Obstetricia y Ginecología

Print version ISSN 0034-7434On-line version ISSN 2463-0225

Abstract

GOMEZ JIMENEZ, Jorge Mario; ZULETA TOBON, Jhon Jairo; CAMPUZANO MAYA, Germán  and  CANTILLO PABON, José. Hepatic dysfunction in preeclampsia: association with high levels of gammaglutamyltransferase. Rev Colomb Obstet Ginecol [online]. 2002, vol.53, n.2, pp.171-177. ISSN 0034-7434.

Objective: To explore the relationships between elevated serum level of gammaglutamyltransferase (eGGT) and preeclampsia (PE) and related complications before 35 weeks of gestational age. Methodology: Cross sectional study. Population and source: 109 pregnant patients before 35 weeks of gestational age [Group I (G I) n = 55 pre-eclamptic patients and group II (G II) n = 54 non pre-eclamptic patients] of the hospitals Universitario San Vicente de Paúl and General de Medellín, between September 1st,1999 and September 1st, 2000. Background: Association between eGGT and PE. Statistical analysis: Kolmogorov-Smirnov´s test to evaluate normality, Spearman´s Rho to continuous variables; Mann-Witney's U test to compare the medians, Relationships by Odds Ratios. Results: There were no differences between both groups when analyzing general characteristics. There was no association between eGGT and pregnant age, gestational age nor parity (Spearman´s rho - 0.03, 0.08 and 0.137 respectively). The medians of gammaglutamyltransferase levels (mGGT) were 22.62 UI/L (range 4.76-142.79) and 17.63 (range 7.22 - 77.86) on G I and G II patients, respectively (p = 0.81, Mann-Witney's U test). Eleven pre-eclamptic pregnant women in G I (20%) had eGGT [arbitrare cutoff > 49.0525 U/L, mayor or equal than percentile 95 (95p) of the controls] in front to 2 non pre-eclamptic women (3.7%) in G II (p = 0.009), odds ratio (OR) 6.5; 95% confidence interval (CI) 1.25-45.02. Fourteen patients in G I had complications attributable to PE, five resulted positive for eGGT in front to 6 positive women of 41 without complications in same group (p = 0.12). Of twenty-five intrauterine growth restriction (IUGR) events in G I, eight resulted positive for eGGT compared to three with eGGT of 30 in the same group which did not exhibit IUGR (p = 0.088). There were six IUGR events in 26 G II negative for eGGT patients that ended its gestation at the source hospitals. Conclusion: eGGT level in pregnancy was defined > p95, like a concentration > 49,0525 UI/L and evidence of an association, though not causal, with severe PE was found.

Keywords : Preeclampsia; gammaglutamyltransferase; Hellp; enzyme.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License